| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.66T | 1.52T | 1.40T | 1.29T | 1.12T |
| Gross Profit | 293.01B | 270.20B | 230.97B | 219.73B | 215.50B |
| EBITDA | 215.31B | 154.80B | 138.75B | 148.74B | 137.64B |
| Net Income | 99.03B | 59.46B | 54.03B | 73.15B | 68.94B |
Balance Sheet | |||||
| Total Assets | 1.81T | 1.58T | 1.42T | 1.30T | 1.10T |
| Cash, Cash Equivalents and Short-Term Investments | 227.52B | 214.26B | 146.66B | 144.67B | 163.59B |
| Total Debt | 482.49B | 493.00B | 383.96B | 376.00B | 288.93B |
| Total Liabilities | 903.81B | 830.19B | 700.40B | 660.71B | 562.76B |
| Stockholders Equity | 898.97B | 743.45B | 704.14B | 629.13B | 538.61B |
Cash Flow | |||||
| Free Cash Flow | 15.49B | 51.19B | 24.18B | -90.36B | 9.94B |
| Operating Cash Flow | 94.85B | 133.67B | 101.76B | 44.09B | 78.42B |
| Investing Cash Flow | -81.97B | -125.77B | -76.30B | -108.55B | -63.60B |
| Financing Cash Flow | -16.94B | 64.00B | -30.21B | 40.15B | -25.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥939.27B | 29.44 | 8.07% | 2.85% | 11.53% | 1.60% | |
73 Outperform | ¥21.67T | 90.04 | 8.95% | 1.88% | 5.02% | 2.02% | |
66 Neutral | ¥426.56B | 15.38 | 11.96% | 3.04% | 2.93% | -27.05% | |
64 Neutral | ¥7.42T | 38.00 | ― | 1.41% | 13.61% | 17.02% | |
63 Neutral | ¥1.87T | 18.90 | 8.05% | 1.58% | 9.30% | 67.08% | |
62 Neutral | ¥2.43T | 164.92 | ― | 2.57% | 4.07% | 533.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |